Related references
Note: Only part of the references are listed.Cuts in cancer research funding due to COVID-19
Talha Khan Burki
LANCET ONCOLOGY (2021)
What constitutes a neglected tropical disease?
Peter J. Hotez et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Research funding after COVID-19
Miguel Prudencio et al.
NATURE MICROBIOLOGY (2020)
Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications
Mariana Pereira Silva et al.
MOLECULES (2020)
The Current Status and Perspectives of Delivery Strategy for Boron-based Drugs
Zhu Yinghuai et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis
Robert T. Jacobs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Boron in drug design: Recent advances in the development of new therapeutic agents
Guilherme Felipe Santos Fernandes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Dimeric benzoboroxoles for targeted activity against Mycobacterium tuberculosis
Collette S. Guy et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance
Laura E. Heller et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2019)
Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis
Neeraj Tiwari et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase
Reetika Manhas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles
Katrien Van Bocxlaer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases
Eun-Young Lee et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Hit Generation in TB Drug Discovery: From Genome to Granuloma
Tianao Yuan et al.
CHEMICAL REVIEWS (2018)
Benzoxaborole compounds for therapeutic uses: a patent review (2010-2018)
Alessio Nocentini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Benzoboroxoles: Synthesis and applications in medicinal chemistry
Gautam R. Mereddy et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2018)
Accelerating the development of therapeutic strategies for drug-resistant tuberculosis
Michael J. Vjecha et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis
Aaron Korkegian et al.
TUBERCULOSIS (2018)
Synthesis of biologically active boron-containing compounds
Fei Yang et al.
MEDCHEMCOMM (2018)
Cinnamoyl-Oxaborole Amides: Synthesis and Their in Vitro Biological Activity
Maureen Gumbo et al.
MOLECULES (2018)
A high throughput screen for next-generation leads targeting malaria parasite transmission
Michael J. Delves et al.
NATURE COMMUNICATIONS (2018)
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
Manel Ouji et al.
PARASITE (2018)
Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
Yi Xia et al.
LIFE SCIENCE ALLIANCE (2018)
Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles
Alessio Nocentini et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate
Yong-Kang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of a Potent and Specific M-tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
Xianfeng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
Ebere Sonoiki et al.
NATURE COMMUNICATIONS (2017)
Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome
Wilfried Moreira et al.
FRONTIERS IN MICROBIOLOGY (2017)
Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis
Sheridan M. Hoy
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis In Vitro
Nipul Patel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors
Liqiang Han et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome
Wilfried Moreira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Recent advancements in the development of anti-tuberculosis drugs
Sarentha Chetty et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets
Alane B. Vermelho et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
Andres Palencia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase
Ebere Sonoiki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase
Andres Palencia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents
Mohammad A. Alam et al.
TETRAHEDRON (2016)
Characterization of the Dynamic Equilibrium between Closed and Open Forms of the Benzoxaborole Pharmacophore
Sergey Vshyvenko et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Boromycin Kills Mycobacterial Persisters without Detectable Resistance
Wilfried Moreira et al.
FRONTIERS IN MICROBIOLOGY (2016)
Recent Developments in the Chemistry and Biological Applications of Benzoxaboroles
Agnieszka Adamczyk-Wozniak et al.
CHEMICAL REVIEWS (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
Yong-Kang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Type-II NADH:quinone oxidoreductase from Staphylococcus aureus has two distinct binding sites and is rate limited by quinone reduction
Filipa V. Sena et al.
MOLECULAR MICROBIOLOGY (2015)
Understanding artemisinin resistance
Carol Hopkins Sibley
SCIENCE (2015)
Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
Wilfried Moreira et al.
MBIO (2015)
An upcoming drug for onychomycosis: Tavaborole
Neha Sharma et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2015)
Mycobacterium tuberculosis Type II NADH-Menaquinone Oxidoreductase Catalyzes Electron Transfer through a Two-Site Ping-Pong Mechanism and Has Two Quinone-Binding Sites
Takahiro Yano et al.
BIOCHEMISTRY (2014)
Synthesis, Characterization, and Antibacterial Activity of Structurally Complex 2-Acylated 2,3,1-Benzodiazaborines and Related Compounds
Divya Kanichar et al.
CHEMISTRY & BIODIVERSITY (2014)
Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei
Puhua Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Bacterial caseinolytic proteases as novel targets for antibacterial treatment
Heike Broetz-Oesterhelt et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
Shyam Sundar et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Post-Translational Regulation via Clp Protease Is Critical for Survival of Mycobacterium tuberculosis
Ravikiran M. Raju et al.
PLOS PATHOGENS (2014)
Boron chemicals in diagnosis and therapeutics
Bhaskar C. Das et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Global Causes of Diarrheal Disease Mortality in Children <5 Years of Age: A Systematic Review
Claudio F. Lanata et al.
PLOS ONE (2013)
The synthesis of benzoxaboroles and their applications in medicinal chemistry
Zhang Jiong et al.
SCIENCE CHINA-CHEMISTRY (2013)
Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase
Qing-Hua Hu et al.
SCIENTIFIC REPORTS (2013)
Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
Yong-Kang Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Aminoacyl-tRNA Synthetase Inhibitors As Potent Antibacterials
P. -C. Lv et al.
CURRENT MEDICINAL CHEMISTRY (2012)
New therapeutic options for onychomycosis
Aditya K. Gupta et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Chalcone-Benzoxaborole Hybrid Molecules as Potent Antitrypanosomal Agents
Zhitao Qiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The life cycle of Trypanosoma (Nannomonas) congolense in the tsetse fly
Lori Peacock et al.
PARASITES & VECTORS (2012)
Mycobacterium tuberculosis ClpP1 and ClpP2 Function Together in Protein Degradation and Are Required for Viability in vitro and During Infection
Ravikiran M. Raju et al.
PLOS PATHOGENS (2012)
The immunological life cycle of tuberculosis
Joel D. Ernst
NATURE REVIEWS IMMUNOLOGY (2012)
Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents
Yong-Kang Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Natural and Synthetic Small Boron-Containing Molecules as Potential Inhibitors of Bacterial and Fungal Quorum Sensing
Valery M. Dembitsky et al.
CHEMICAL REVIEWS (2011)
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Matthias Scholz et al.
CHEMICAL REVIEWS (2011)
Boron-containing inhibitors of synthetases
Stephen J. Baker et al.
CHEMICAL SOCIETY REVIEWS (2011)
In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
Dharminder Chauhan et al.
CLINICAL CANCER RESEARCH (2011)
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
D. Chen et al.
CURRENT CANCER DRUG TARGETS (2011)
Boron-based drugs as antiprotozoals
Robert T. Jacobs et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis
Robert T. Jacobs et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and Structure-Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents
Dazhong Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Topological Principles of Borosilicate Glass Chemistry
Morten M. Smedskjaer et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
An efficient synthesis for a new class antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
Yong-Kang Zhang et al.
TETRAHEDRON LETTERS (2011)
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
Robert T. Jacobs et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis
Bakela Nare et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Synthesis, in Vitro and in Vivo Biological Evaluation, and Comprehensive Understanding of Structure-Activity Relationships of Dipeptidyl Boronic Acid Proteasome Inhibitors Constructed from β-Amino Acids
Yongqiang Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents
Dazhong Ding et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Short Report: Relapse of Visceral Leishmaniasis after Miltefosine Treatment in a Nepalese Patient
Basu Dev Pandey et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Therapeutic potential of boron-containing compounds
Stephen J. Baker et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Crystal Structures of the Human and Fungal Cytosolic Leucyl-tRNA Synthetase Editing Domains: A Structural Basis for the Rational Design of Antifungal Benzoxaboroles
Elena Seiradake et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Benzoxaboroles - Old compounds with new applications
Agnieszka Adamczyk-Wozniak et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2009)
Biology of trans-Translation
Kenneth C. Keiler
ANNUAL REVIEW OF MICROBIOLOGY (2008)
Synthesis, Characterization, and Antifungal Activity of Boron-Containing Thiosemicarbazones
Justin W. Hicks et al.
CHEMISTRY & BIODIVERSITY (2008)
Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones
Jose C. Aponte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site
Fernando L. Rock et al.
SCIENCE (2007)
Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30(+) anaplastic large cell lymphoma
P. Bonvini et al.
LEUKEMIA (2007)
Polyadenylation factor CPSF-73 is the pre-mRNA 3′-end-processing endonuclease
Corey R. Mandel et al.
NATURE (2006)
Crystal structures of the editing domain of Escherichia coli leucyl-tRNA synthetase and its complexes with Met and Ile reveal a lock-and-key mechanism for amino acid discrimination
YQ Liu et al.
BIOCHEMICAL JOURNAL (2006)
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
M Groll et al.
STRUCTURE (2006)
Inhibition of peptide bond formation by pleuromutilins:: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin
F Schlünzen et al.
MOLECULAR MICROBIOLOGY (2004)
Steady-state brain concentrations of antihistamines in rats - Interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding
KMM Doan et al.
PHARMACOLOGY (2004)
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates
ASG Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
